Stockreport

Sonnet BioTherapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]

Sonnet BioTherapeutics Holdings, Inc.  (SONN) 
PDF Sonnet BioTherapeutics regains compliance with Nasdaq's minimum bid price requirementOct. 04, 2022 8:59 AM ETSonnet BioTherapeutics Holdings, Inc. ()By:Mary Christine Jo [Read more]